This FDA audit training provides an overview of the audit readiness process from internal evaluation of your quality systems to the logistics of the audit itself; with key emphasis placed on equipping you and your team with the skills needed to present expert testimony during interviews with regulators.
Why Should You Attend:
Pharmaceutical, Medical Device and Biologics industries are subject to oversite inspections by FDA and other regulatory bodies from the geographies where products are marketed. A firm’s successful completion of a regulatory audit is critical to its continued operation and financial viability. Failure can mean delays in product approvals, time consuming and costly remediation efforts and damage to the firm’s reputation for high quality products.
This webinar will provide essential information and a strategy for being in a permanent state of readiness for a regulatory audit. You and every member of your team can benefit by becoming acquainted with the overall audit readiness process and preparing them for the potential of being interviewed by an auditor.
Areas Covered in the Webinar:
Learning Objectives:
Who Will Benefit:
Instructor Profile:
Philip Russ, is an experienced quality/compliance professional with 20 years experience in the pharmaceutical, medical device and biologics industry. He has a record of success developing and managing quality systems to support these businesses.
He has a breadth of experience performing/coordinating compliance audits involving CFR210/211, CFR820, ISO13485, QSR/PAL and CMDCAS regulations.
Mr. Russ has provided expert counsel in quality systems for early development projects; pioneering drug/medical device/drug combo quality systems and compliance initiatives; designing statistical and attribute analysis programs for manufacturing processes; continuous improvement, auditing, supplier quality management, technology transfer and validation support; statistical process controls; QA expertise for development activities, design controls and GCP for both medical device and drug products.